Rajiv Patel, Director, Member of Group Owning 10%, Ten Percent Owner at Nexvet Biopharma, holds 3.48M shares in Lantheus (Ticker: LNTH), holds 2.51M shares in Nexvet Biopharma (Ticker: NVET). Most recently, Rajiv Patel Sold ― shares of Lantheus on Aug 21, 2025 for an estimated value of $191.21M.
What is the percentage of profitable transactions made by Rajiv Patel?
The percentage of profitable transactions made by Rajiv Patel is 40%.
What is the average return per transaction made by Rajiv Patel?
The average return per transaction made by Rajiv Patel is -15.00%.
What stocks does Rajiv Patel hold?
Rajiv Patel holds: NVET, LNTH stocks.
What was Rajiv Patel’s latest transaction?
Rajiv Patel latest transaction was an Informative Sell of $191.21M.
What was Rajiv Patel's most profitable transaction?
Rajiv Patel’s most profitable transaction was an Informative Buy of NVET stock on October 2, 2015. The return on the trade was 1.70%.
What is Rajiv Patel's role in Nexvet Biopharma?
Rajiv Patel's role in Nexvet Biopharma is Director, Member of Group Owning 10%, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.